These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9592977)

  • 61. [The relationship between expression of lung resistance-related protein gene or multidrug resistance-associated protein gene and prognosis in newly diagnosed acute leukemia].
    Zhao Y; Yu L; Wang Q; Lou F; Pu J
    Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):183-5. PubMed ID: 11940320
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Expression of the multidrug resistance P glycoprotein in newly diagnosed adult acute lymphoblastic leukemia: absence of correlation with response to treatment.
    Wattel E; Lepelley P; Merlat A; Sartiaux C; Bauters F; Jouet JP; Fenaux P
    Leukemia; 1995 Nov; 9(11):1870-4. PubMed ID: 7475277
    [TBL] [Abstract][Full Text] [Related]  

  • 63. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
    Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
    Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Different effects of metabolic inhibitors and cyclosporin A on daunorubicin transport in leukemia cells from patients with AML.
    Knaust E; Porwit-MacDonald A; Gruber A; Xu D; Peterson C
    Leuk Res; 2003 Feb; 27(2):183-91. PubMed ID: 12526924
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Flow cytometric study of idarubicin and daunorubicin accumulation and the effect of verapamil in leukemic cell lines and fresh cells from patients with acute non-lymphoblastic leukemia.
    Boiron JM; Belloc F; Montastruc M; Cony-Makhoul P; Dumain P; Marit G; Mahon FX; Puntous M; Lopez F; Lacombe F
    Leuk Res; 1994 May; 18(5):313-8. PubMed ID: 8182921
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Idarubicin overcomes P-glycoprotein-related multidrug resistance: comparison with doxorubicin and daunorubicin in human multiple myeloma cell lines.
    Roovers DJ; van Vliet M; Bloem AC; Lokhorst HM
    Leuk Res; 1999 Jun; 23(6):539-48. PubMed ID: 10374847
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group.
    Olson DP; Taylor BJ; La M; Sather H; Reaman GH; Ivy SP
    Leuk Lymphoma; 2005 May; 46(5):681-91. PubMed ID: 16019505
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Screening for multidrug resistance in leukemia: cell reactivity to MRK-16 correlates with anthracycline retention and sensitivity of leukemic cells.
    Michieli M; Damiani D; Michelutti A; Grimaz S; Geromin A; Fanin R; Russo D; Masolini P; Baccarani M
    Leuk Lymphoma; 1996 Sep; 23(1-2):99-105. PubMed ID: 9021691
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vivo uptake of daunorubicin by acute myeloid leukemia (AML) cells measured by flow cytometry.
    Kokenberg E; Sonneveld P; Delwel R; Sizoo W; Hagenbeek A; Löwenberg B
    Leukemia; 1988 Aug; 2(8):511-7. PubMed ID: 3166077
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia.
    Legrand O; Simonin G; Beauchamp-Nicoud A; Zittoun R; Marie JP
    Blood; 1999 Aug; 94(3):1046-56. PubMed ID: 10419897
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.
    Coley HM; Verrill MW; Gregson SE; Odell DE; Fisher C; Judson IR
    Eur J Cancer; 2000 May; 36(7):881-8. PubMed ID: 10785593
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Predictive value of intracellular accumulation of daunorubicin and P-glycoprotein expression simultaneously determined by flow cytometry in adult acute myeloid leukemias].
    Guerci A; Merlin JL; Missoum N; Feldmann L; Marchal S; Guerci O
    Ann Biol Clin (Paris); 1996; 54(1):17-9. PubMed ID: 8731790
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Drug resistance proteins LRP, Pgp, MRP1, MRP3 and MRP5 in ovarian cancer patients].
    Sedláková I; Laco J; Tošner J; Spaček J; Cermáková E
    Ceska Gynekol; 2013 Dec; 78(6):545-53. PubMed ID: 24372433
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL.
    Ross DD; Wooten PJ; Tong Y; Cornblatt B; Levy C; Sridhara R; Lee EJ; Schiffer CA
    Blood; 1994 Mar; 83(5):1337-47. PubMed ID: 8118035
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multidrug resistance analysis in lymphoproliferative disease of large granular lymphocytes.
    Lamy T; Drenou B; Fardel O; Amiot L; Grulois I; Le Prise PY; Loughran TP; Fauchet R
    Br J Haematol; 1998 Mar; 100(3):509-15. PubMed ID: 9504633
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Daunorubicin pharmacokinetics and the correlation with P-glycoprotein and response in patients with acute leukaemia.
    Galettis P; Boutagy J; Ma DD
    Br J Cancer; 1994 Aug; 70(2):324-9. PubMed ID: 7914424
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influence of SDZ-PSC833 on daunorubicin intracellular accumulation in bone marrow specimens from patients with acute myeloid leukaemia.
    Merlin JL; Guerci AP; Marchal S; Bour C; Colosetti P; Kataki A; Guerci O
    Br J Haematol; 1998 Nov; 103(2):480-7. PubMed ID: 9827923
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Preliminary results in secondary acute non-lymphocytic leukemia (ANLL) treated with Idarubicin.
    Parmentier C; Finaud M; Schlumberger M; Morardet N; Berger R; Bayle C; Carde P; Hurteloup P; Hayat M
    Nouv Rev Fr Hematol (1978); 1985; 27(6):393-5. PubMed ID: 3867854
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours.
    Zurita AJ; Diestra JE; Condom E; García Del Muro X; Scheffer GL; Scheper RJ; Pérez J; Germà-Lluch JR; Izquierdo MA
    Br J Cancer; 2003 Mar; 88(6):879-86. PubMed ID: 12644825
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Liposome-encapsulated daunorubicin for PGP-related multidrug resistance.
    Michieli M; Damiani D; Ermacora A; Masolini P; Michelutti A; Michelutti T; Russo D; Pea F; Baccarani M
    Br J Haematol; 1999 Jul; 106(1):92-9. PubMed ID: 10444168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.